On August 20, 2025 Olema Pharmaceuticals, Inc. ("Olema", or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, reported that the Company will participate in the following upcoming investor conferences (Press release, Olema Oncology, AUG 20, 2025, View Source [SID1234655405]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2025 Biopharma Back to School Conference
Date and Time: September 2, 2025 at 4 p.m. ET
Format: Fireside Chat
Location: Boston, MA

Wells Fargo 2025 Healthcare Conference
Date and Time: September 3, 2025 at 3:45 p.m. ET
Format: Presentation
Location: Boston, MA

Cantor Global Healthcare Conference 2025
Date and Time: September 4, 2025 at 11:30 a.m. ET
Format: Fireside Chat
Location: New York, NY

Morgan Stanley 23rd Annual Global Healthcare Conference
Date and Time: September 8, 2025 at 10 a.m. ET
Format: Fireside Chat
Location: New York, NY

H.C. Wainwright 27th Annual Global Investment Conference
Date and Time: September 9, 2025 at 9:30 a.m. ET
Format: Fireside Chat
Location: New York, NY

Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.